Brief: TransCode Therapeutics Announces Positive Results In Non-Human Primates
31/07/2023 12:19
July 31 (Reuters) - Transcode Therapeutics Inc RNAZ.O :
* TRANSCODE THERAPEUTICS ANNOUNCES POSITIVE RESULTS IN
NON-HUMAN
PRIMATES WITH ITS LEAD THERAPEUTIC CANDIDATE, TTX-MC138
* TRANSCODE THERAPEUTICS - TTX-MC138 SUCCESSFULLY DELIVERED
&
DEMONSTRATED PRELIMINARY EFFICACY IN CASE STUDY OF SPONTANEOUS
FELINE MAMMARY CARCINOMA
Source text for Eikon: ID:nGNXR2d07
Further company coverage: RNAZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors